177 related articles for article (PubMed ID: 12083632)
41. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
Yang CH; Kuo ML; Chen JC; Chen YC
Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
[TBL] [Abstract][Full Text] [Related]
42. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
43. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
45. Arsenic-induced apoptosis in malignant cells in vitro.
Akao Y; Yamada H; Nakagawa Y
Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
[TBL] [Abstract][Full Text] [Related]
46. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).
Michel L; Dupuy A; Jean-Louis F; Sors A; Poupon J; Viguier M; Musette P; Dubertret L; Degos L; Dombret H; Bachelez H
J Invest Dermatol; 2003 Oct; 121(4):881-93. PubMed ID: 14632209
[TBL] [Abstract][Full Text] [Related]
47. Morphological and functional changes of mitochondria in apoptotic esophageal carcinoma cells induced by arsenic trioxide.
Shen ZY; Shen J; Li QS; Chen CY; Chen JY; Yi Z
World J Gastroenterol; 2002 Feb; 8(1):31-5. PubMed ID: 11833066
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
Benbijja M; Mellouk A; Bobé P
Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
[TBL] [Abstract][Full Text] [Related]
49. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
[TBL] [Abstract][Full Text] [Related]
50. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
51. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
[TBL] [Abstract][Full Text] [Related]
52. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
[TBL] [Abstract][Full Text] [Related]
53. [In vitro study on arsenic trioxide-induced apoptosis of retinoic acid resistant acute promyelocytic leukemia cell line(MR-2)].
Cai X; Jia P; Shi X
Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):339-41. PubMed ID: 11189513
[TBL] [Abstract][Full Text] [Related]
54. [In vitro study on arsenic trioxide-inducing apoptosis in primary acute promyelocytic leukemie cells].
Tang W; Chen G; Shen Z; Chen L; Shi X; Jia P; Shi G; Ni J; Chen S; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 1997 Dec; 18(12):623-6. PubMed ID: 15625759
[TBL] [Abstract][Full Text] [Related]
55. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
56. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
Rojewski MT; Körper S; Schrezenmeier H
Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
[TBL] [Abstract][Full Text] [Related]
57. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
58. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
59. As2O3 induces apoptosis of the human B lymphoma cell line MBC-1.
Shen L; Chen TX; Wang YP; Lin Z; Zhao HJ; Zu YZ; Wu G; Ying DM
J Biol Regul Homeost Agents; 2000; 14(2):116-9. PubMed ID: 10841286
[TBL] [Abstract][Full Text] [Related]
60. [Double effects of arsenic trioxide (As2O3) on acute promyelocytic leukemic cell line].
Tang W; Chen G; Shi G
Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):509-12. PubMed ID: 9772451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]